Journal article

Vinpotropil in the treatment of dyscirculatory encephalopathy with cognitive impairment without dementia

Zakharov V ...see all

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, vol. 110, issue 11 (2010) pp. 13-16

  • 11


    Mendeley users who have this article in their library.
  • 1


    Citations of this article.
Sign in to save reference


The fixed combination containing 5 mg of vinpocetine and 400 mg of pyracetam (vinpotropil) was prescribed to 349 patients with dyscirculatory encephalopathy, I-II stages in dose one capsule three times a day during 3 months. After this treatment, repeated neuropsychological testing showed significant diminishing of dysexecutive cognitive impairment linked with frontal lobes dysfunction. The cognitive improvement was associated with the regress of subjective neurological symptoms like headache, dizziness, tinnitus, fatigue and insomnia. Vinpotropil was safe and well tolerated in elderly patients with chronic cerebral vascular insufficiency.

Author-supplied keywords

  • Dyscirculatory encephalopathy
  • Nootropics
  • Vascular cognitive impairment
  • Vasoactive treatment
  • Vinpotropil

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • V. V. Zakharov

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free